Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation

about

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors.

P2860

Q37709050-88940EAF-5A7A-421B-B1B4-A486631A6024

P2860

Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation

Item

http://www.wikidata.org/entity/Q41908351

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Lung Adenocarcinoma with Pulmo ...... tic Heterozygous EGFR Mutation

@en

type

Item

label

Lung Adenocarcinoma with Pulmo ...... tic Heterozygous EGFR Mutation

@en

prefLabel

Lung Adenocarcinoma with Pulmo ...... tic Heterozygous EGFR Mutation

@en

P1476

Lung Adenocarcinoma with Pulmo ...... tic Heterozygous EGFR Mutation

@en

P2093

Alexandre Schaller

http://www.w3.org/2001/XMLSchema#string

Benjamin Renaud-Picard

http://www.w3.org/2001/XMLSchema#string

Bertrand Mennecier

http://www.w3.org/2001/XMLSchema#string

Elisabeth Quoix

http://www.w3.org/2001/XMLSchema#string

Michèle Beau-Faller

http://www.w3.org/2001/XMLSchema#string

Noëlle Weingertner

http://www.w3.org/2001/XMLSchema#string

P2860

The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis.

Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report

Detection of mutations in EGFR in circulating lung-cancer cells

EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications.

Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer.

Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer.

Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling.

A rare case of non-small cell carcinoma of lung presenting as miliary mottling.

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.

Uncommon epidermal growth factor receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance.

P304

769-773

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1159/000369526

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gilbert Massard

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272834600

http://www.w3.org/2001/XMLSchema#string

P698

25722667

http://www.w3.org/2001/XMLSchema#string

P932

4322700

http://www.w3.org/2001/XMLSchema#string

Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation

about

P2860

P2860

Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932